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Introduction
Currently, one of the most important areas of research in bioinorganic chemistry is the design and synthesis of transition metal complexes as efficient anticancer agents [1] [2] [3] [4] [5] . In this connection, Pd(II) complexes have attracted the attention of bioinorganic chemists as potential alternative to cisplatin that is being currently administered because of the fact that the Pd(II) complexes can undergo aquation and ligand exchange reactions 10 5 times faster than the corresponding Pt(II) complexes. Hence, a new area of active research in bioinorganic chemistry has emerged recently targeting new drugs of cancer cell specific [6] [7] [8] and a number of Pd(II) complexes [9] [10] [11] [12] [13] [14] [15] have even shown better anticancer properties that that of Pt(II) complexes due to the structural and thermodynamic similarities between Pd(II) and Pt(II) complexes.
As far as the ligands used for the synthesis of new Pd(II) complexes is concerned, quinolines are best suited since they are a class of compound that has been used in agriculture as fungicide besides being used as preservatives in wood, paper and textile industries [16] . In this connection, it is to be noted that alkaloid and alkaloid based compounds contain quinoline as an important structural unit which exhibited substantial biological activities [17, 18] . Moreover, the biological activities such as antioxidation, antiproliferation and anticancer have also been exhibited by the derivatives of quinolones [19] [20] [21] [22] . This has really created a special interest in the synthesis of transition metal complexes of quinolines and to study their role in inhibiting cancer cell proliferation and microbial growth [23] [24] [25] [26] . The results have indicated that the complexes thus prepared have not only shown significant pharmacological properties but also revealed interesting coordination modes of quinolines in the complexes. Hence, we synthesized two new Pd(II) complexes from aquinoline derivative. Interestingly, the complexes contain the ligand coordinated through the quinoline pyridine nitrogen atom only. Herein, we report the synthesis, structures, DNA interactions, protein binding, molecular docking and cytotoxicity studies of mononuclear palladium complexes of 2-methyl 4-amino quinoline.
Results and discussion

Synthesis
The 
Spectroscopy
Electronic spectra of the complexes showed two strong absorption bands, one in the regions at 260-264 corresponding to intra ligand transition and the other at 315-328 nm which has been assigned to ligand to metal charge transfer transition [27] . (Table S1 ).The crystal structure of complex were identified but no π-π interactions were seen in this case ( Table 1 ). The data collection and parameters of refinement progression are given in Table 3 and important bond lengths and bond angles are summarized in Table 4 . Table 4 . Particular bond lengths (Å) and bond angles (˚) in the complexes
Bond angle (˚)
Cl2-Pd1-Cl1-91.37 (3) P1-Pd1-Cl1-179.41 (3) P1-Pd1-Cl2-89.20 (3) N1-Pd1-Cl1-89.77 (7) N1-Pd1-Cl2-177.30 (8) N1-Pd1-P1-89.67 (7) C1-P1-Pd1-114.44 (10) C7-P1-Pd1-115.20 (10) C13-P1-Pd1-114.09 (11) C2-N1-Pd1-121.68 (16) Pd1-As1-2.3506 (3) Pd1-Cl2-2.2945 (6) Pd1-Cl1-2.3411 (7) Pd1-N1-2.040(2)
Cl2-Pd1-As1-88.849 (17) Cl2-Pd1-Cl1-91.51 (3) Cl1-Pd1-As1-178.71 (3) N1-Pd1-As1-92.14 (5) N1-Pd1-Cl2-176.72 (6) N1-Pd1-Cl1-87.57 (6) Cl1-As1-Pd1-113.83 (7) C23-As1-Pd1-113.59 (7) C23-As1-Cl1-103.95 (10) C17-As1-Pd1-115.38 (7) C6-N1-Pd1-118.65 (16) DNA binding studies DNA binding of the ligand and the new compounds was carried out as it is considered one of the important aspects in deciding whether a compound could be an anticancer drug [28, 29] .
Electronic absorption titration is the effective method to test the binding modes of compounds with DNA [30] . The spectral features will be seen in terms of hyperchromism and hypochromism concerned with modifications of DAN double helix structure. The interaction of the compounds with CT-DNA was followed by recording the UV-visible spectra by the 
Ethidiumbromide(EB) displacement study
Though the electronic absorption studies indicate that the compounds efficiently bind to DNA, it
is not enough to conclusively say that there exists a binding and hence, there is a need to prove this by other studies. In this connection, ethidiumbromide(EB) displacement experiments are considered to be the best technique to confirm the binding mode. Since EB forms soluble compounds with nucleic acids and emits intense fluorescence in the presence of CT-DNA due to the intercalation of the planar phenanthridine ring between adjacent base pairs on the double helix [32] , one can obtain information on the binding mode of any compound with DNA. In the EB displacement study, there is a decrease in the intensity of fluorescence as and when EB is displaced from a DNA sequence by a quencher and the quenching will be due to the reduction of the number of binding sites on the DNA that is available to EB. Figure S3 shows the fluorescence quenching spectra of DNA bound EB by compounds and illustrate that as the concentration of the compounds increases the emission band at 626 nm showed hypochromism.
The observed decrease in the fluorescence intensity indicates that the EB molecules have been displaced from their DNA binding sites and are replaced by the test compounds [33, 34] . The quenching constants and binding constants can be analyzed through a couple of equations. The following Stern-Volmer equation is used obtain the quenching constant,
Where I0 and I represent the emission intensities in the absence and presence of the complexes, . These values do indicate that the ligand and Pd(II) complexes interact with DNA through intercalation mode of binding [35] .
Protein binding studies
In order to find out the interaction of the compounds with protein, we undertook the study of interaction of our compounds with BSA. A constant concentration of BSA (1 µM) was titrated with various concentrations of the compounds (0-100 µM) and the fluorescence emission spectra were recorded ( Figure S5 ). It can be seen that the effect of compounds on BSA resulted in a significant decrease in the fluorescence intensity at 347 nm with no shift in their emission wavelength maxima. The observed decrease in the fluorescence intensity could be attributed to the fact that the active site in the protein is buried in a hydrophobic environment [36, 37] . By using the following Scatchard equation, the fluorescence quenching data can be analyzed.
Where Kbin is the binding constant of the compound with BSA and n is the number of binding sites. 
Synchronous fluorescence spectra
In addition to the studies conducted as above, synchronous fluorescence spectral studies have also been employed to observe the structural changes occurred to BSA upon the addition of compounds, particularly in the vicinity of the fluorophore functional groups [39] . It is known that fluorescence of BSA is due to the presence of tyrosine, tryptophan and phenylalanine residues and hence, fluorescence spectroscopic methods can be effectively used to study the conformation of serum protein. In this connection, it has been shown that the difference between the excitation wave length and emission wavelength (∆λ = λem -λex) will indicate the type of chromophores.
whereas a larger ∆λ = 60 nm is characteristic of tryptophan. Figure 11 shows the synchronous fluorescence spectra of BSA with various concentrations of test compounds recorded at ∆λ = 60 nm. In the synchronous fluorescence spectra of BSA at ∆λ = 60, the addition of the compounds to the solution of BSA resulted in a decrease of the fluorescence intensity of BSA at 348 nm for the ligand and the complexes indicating that the tryptophan residues were affected by increasing the concentration of compounds. The result of the BSA protein binding experiments with our compounds has already revealed that the binding of the compounds with BSA is mainly hydrophobic in nature. Moreover, the binding strength of the Pd(II) complexes with BSA is significantly higher than that of the ligand, which can be explained by the fact that the hydrophobicity of the complex is greater than that of the ligand. So, the strong interaction between the Pd(II) complexes and BSA suggested that this compound can easily be stored in protein and can be released at desired target areas. Hence, it will be interesting to study the pharmacological properties of Pd(II) complexes. The results obtained from molecular docking studies revealed that the interaction between complex 1 and BSA is with the highest binding energy dominated by hydrophobic forces. 
In vitro cytotoxic activity evaluation
The positive results obtained from the biological studies, namely, DNA binding, BSA binding, and BSA docking studies for our compounds prompted us to test their cytotoxicity against a panel of human lung cancer (A-549) and breast cancer (MCF-7) cell lines. Doxorubicin and cisplatin were used as a positive control to assess the cytotoxicity of the test compounds. The compounds were analyzed by means of cell inhibition expressed as IC50 values and bar chart which are shown in Table 7 and in Figure 13 
Conclusion
The synthesis and characterization of square planar Pd(II) complexes are described. The 
EXPERIMENTAL SECTION
Materials and methods.
All the chemicals were purchased from sigma Aldrich and used as received. Solvents were purified and dried according to standard procedures [41] . Single crystal X-ray diffraction studies X-ray diffraction data for [PdCl2(L)(PPh3)] and [PdCl2(L)(AsPh3)] were collected at 100K on a Bruker APEX II diffractometer using Mo-Kα radiation (λ = 0.71073 Å). Data collections were performed using a CCD area detector from a single crystal mounted on a glass fibre. Absorption corrections were based on equivalent reflections using SADABS [50] . The structures were solved using Superflip [51] and all of the structures were refined against F 2 in SHELXL [52] using Olex2 [53] . All of the non-hydrogen atoms were refined anisotropically. While all of the hydrogen atoms were located geometrically and refined using a riding model except for the hydrogen atoms that are attached to the amine N which were located in the difference map, in the case of [PdCl2(L)(PPh3)] restraints were applied to the N-H distance and thermal parameters.
Crystal structure and refinement data are given in 
